Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D. - Sandmann L; Jachs M; Tergast TL; Hartl L; Bremer B; Kabelitz MA; Schwarz M; Egge JFM; Balcar L; Hofer BS; Falk CS; Stättermayer AF; et al. (JHEP reports : innovation in hepatology, 2025)